29.11.2018 23:30:00
|
Leidos Awarded Contract to Help Eliminate Chemical Weapon Stockpiles
RESTON, Va., Nov. 29, 2018 /PRNewswire/ -- Leidos (NYSE: LDOS), a FORTUNE® 500 science and technology leader, has been awarded a $118 million contract by the Department of Defense to provide administrative and technical services necessary to support U.S. chemical weapons stockpile demilitarization facilities. The single award, cost-plus-fixed-fee contract has a one-year base followed by nine option years. Work will be done in Alabama, Colorado, Maryland, and Kentucky.
The contract supports the Program Executive Office for Assembled Chemical Weapons Alternatives, which is responsible for the safe and environmentally sound destruction of the nation's remaining chemical weapons stockpiles at the Pueblo Chemical Depot, Colo. and Blue Grass Army Depot, Ky. The Leidos team will deliver services for the systemization, operation, and closure of these demilitarization facilities.
Leidos has supported this mission for more than 25 years, during which chemical weapons were successfully eliminated at several sites across the country while protecting the public, workers, and environment. The company has developed tools and processes for integration across the program, cultivated a team with niche capabilities, and has engaged a strategic network of small businesses to provide subject matter expertise.
"Leidos has an extensive history supporting U.S. Army programs, and over the years we have made long-term investments in our people, capabilities, and execution to support this critical elimination mission through completion," said Senior Vice President Tom Dove, Leidos Logistics and Mission Support. "We're honored to continue being part of the solution to rid our nation of hazardous chemical weapons while ensuring the safety of the public."
About Leidos
Leidos is a Fortune 500® information technology, engineering, and science solutions and services leader working to solve the world's toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company's 32,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $10.17 billion for the fiscal year ended December 29, 2017. For more information, visit www.Leidos.com.
Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company's Annual Report on Form 10-K for the period ended December 29, 2017, and other such filings that Leidos makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.
Contact: | Melissa Koskovich | Erin Tindell |
(571) 526-6850 | (571) 526-6996 | |
View original content to download multimedia:http://www.prnewswire.com/news-releases/leidos-awarded-contract-to-help-eliminate-chemical-weapon-stockpiles-300757982.html
SOURCE Leidos
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!